New discovery being dubbed as a 'super antibody'

By Admin
Share
A ‘super antibody which fights against all types of influenza A has been discovered by a team of Swiss and British researchers. The scientists ar...

A ‘super antibody’ which fights against all types of influenza A has been discovered by a team of Swiss and British researchers.

The scientists are now hopeful the finding could lead to the development of an emergency treatment for the virus and revolutionise flu vaccines.

In the current situation, flu vaccine makers have to adapt their jabs every year to make sure they are able to combat the seasonal flu strains.

However, the new development looks like it could act as a universal vaccine which has the ability to fight many types of the flu virus.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

After looking at 100,000 cell samples, the scientists were able to identify an antibody which effectively targeted the haemagglutinin protein which is found on the surface of all influenza A viruses.

Sir John Skehel, a Medical Research Council scientist who worked on the project, said in a media interview: “We've tried every subtype of influenza A and it interacts with them all.

“We eventually hope it can be used as a therapy by injecting the antibody to stop the infection.”

Meanwhile, the director of the Institute for Research in Biomedicine in Switzerland, Antonio Lanzavecchia, stated: “As the first and only antibody which targets all known subtypes of the influenza A virus, FI6 represents an important new treatment option.”

The findings of the experiments have been published in the Science Express journal. 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma